Co-circulation of Three HTLV-2 Subtypes and Distinct Immune signatures in Asymptomatic People Living with HTLV in the Western Brazilian Amazon
Year: 2026
Type: preprint
Study design: Observational Study
Abstract: Background HTLV is endemic in the Brazilian Amazon, but the diversity of circulating strains in Amazonas remains poorly characterized, and it is still unclear whether asymptomatic carriage is associated with a distinct systemic immune profile. We combined phylogenetic characterization with serum cytokine and chemokine profiling to address both questions. Methods Forty prospective blood donors with confirmed HTLV-1/2 infection and 30 HTLV-negative blood donors were included. The 5′ LTR region was amplified by nested PCR, and 40 amplicons underwent Sanger sequencing and maximum-likelihood phylogenetic analysis. Serum cytokines, chemokines, and growth factors were quantified by multiplex immunoassay. Immune profiles were evaluated using univariate comparisons, correlation analysis, principal component analysis, PERMANOVA, and sensitivity analyses. Results All HTLV-1 sequences belonged to the Cosmopolitan subtype, Transcontinental subgroup (HTLV-1aA; n = 27), whereas HTLV-2 segregated into three co-circulating subtypes: 2a (n = 1), 2b (n = 4) and 2c (n = 8). After correction for multiple testing, five mediators were higher in carriers than in controls, with moderate to large effect sizes (CCL5, IL-13, CXCL10, IL-18 and IL-4) and no growth factor differed. CCL5, CXCL10 and IL-13 were elevated in both viral types and IL-18 in HTLV-2 only, but no mediator differed between HTLV-1 and HTLV-2. Carriers also showed increased network connectivity among chemokines and type 1 and type 2 cytokines, and a significant global shift in mediator composition (PERMANOVA R² = 0.047, p = 0.002). Conclusion Our findings reveal the co-circulation of three HTLV-2 subtypes in Amazonas and a distinct circulating immune mediator profile in asymptomatic carriers, mainly driven by CCL5, CXCL10 and IL-13. Molecular surveillance should therefore extend into structured clinical follow-up, as asymptomatic infection does not imply immunological quiescence.
Source: Research Square
Authors: Kerollayne Costa Silva, Victória Karoline da Silva Araújo, Felipe Araújo Santos, Uzamôr Henrique Soares Pessoa, Jean de Melo Silva, Allyson Guimarães Costa, Giselle Moura Guimarães-Marques, Jacqueline Silva Batista, Dayane Andriotti Otta, Andréa Teixeira-Carvalho, Fernanda Khouri Barreto, Natália Rocha Guimarães, Luiz Carlos Junior Alcantara, Gemilson Soares Pontes
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7226019743
